By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...

Weight-loss drugs are this decade’s blockbuster medicines. Drugs like Ozempic, Wegovy, and Mounjaro help people with diabetes ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...

In the M-ACCEL trial, HU6-induced weight loss was exclusively attributed to fat loss, with no statistically significant loss ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...